Dr. Makker on Synergy Between Lenvatinib and Pembrolizumab in Endometrial Cancer
2 Visningar
administrator
09/30/23
Vicky Makker, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the synergy between lenvatinib and pembrolizumab in the treatment of patients with endometrial cancer.
Visa mer
Facebook-kommentarer
Inga kommentarer hittades